Journal of Commercial Biotechnology — January 2010 issue now available

The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 16, Issue 1

Time for a new business model? (free full-text)
Yali Friedman

Why data exclusivity is the new patent protection
Peter Pitts

Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski and Elizabeth A Jex

Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb
Nigel Borshell and Adrian Dawkes

Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms
Mark J Ahn, Michael Meeks, Sally Davenport and Rebecca Bednarek

Intellectual property landscape and patenting opportunity in biofuels
Ramasamy Mannan

Challenges and opportunities in the licensing of renewable technologies
Meredith Lloyd-Evans, Mike Gilbert and Ilian P Iliev

Ethiopia: Biotechnology for development
Desta Berhe Sbhatu

Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economy
Olivia Harvey

Book Review: Health-care investing: Profiting from the new world of pharma, biotech and health-care services
Frank LaSaracina

Book Review: Aging, Biotechnology, and the Future
Harley King

Using IP audits to optimize IP assets
James G Cullem